Pliant to get $4M milestone from Novartis as fibrosis program moves into development
Pliant Therapeutics (PLRX) said it advanced a fibrosis-directed integrin target into development as part of a 2019 collaboration with Novartis (NVS).The South San…
Pliant to get $4M milestone from Novartis as fibrosis program moves into development
Pliant Therapeutics (PLRX) said it advanced a fibrosis-directed integrin target into development as part of a 2019 collaboration with Novartis (NVS).The South San…